Growing Your Wealth: Analyzing Signet Financial Management's Q4 2022 vs. Q1 2023 13F Holdings Comparison
Ava Hoppe | 28 April, 2023
As an investor, it's crucial to regularly review your portfolio to ensure that your holdings align with your investment goals. One common tool used for portfolio analysis is the 13F filing. This report lists the portfolio holdings of institutional investors with over $100 million in assets under management. This blog post will examine the Q4 2022 vs. Q1 2023 13F holdings comparison of Signet Financial Management, LLC.
Signet Financial Management, LLC is an independent, fee-only, registered investment advisor based in Charlottesville, Virginia. They provide investment management and financial planning services to high net worth individuals and families, endowments, and foundations. Their investment philosophy combines both passive and active investment strategies, focusing on producing long-term results while minimizing risk.
The Q4 2022 vs. Q1 2023 13F holdings comparison of Signet Financial Management, LLC summarizes the changes in holdings of the firm over the past three months. The comparison includes the issuer name, option type, number of shares held, the value of the shares in thousands of dollars, and the percentage change between the two quarters.
Apple Inc. (AAPL) remained the top holding of Signet Financial Management, LLC, with a slight decrease of 0.12% in shares held. However, the value of the shares increased by 26.8%. The firm's second-largest holding, SPDR Ser Tr (SPYV), increased by 2.59% in shares and 7.4% in value. A similar trend was observed for most of the top holdings, indicating a positive outlook on their performance.
One of the most significant changes in holdings was observed in the holding of SPDR Ser Tr (TIPX) with a decrease of 22.32% in shares held and a decrease of 20.3% in the value of the shares. The details suggest that Signet Financial Management, LLC has lost confidence in the performance of the fund and decided to reduce its position.
The firm's holding in Lilly Eli & Co (LLY) experienced a massive decline of 51.8% in the value of shares, indicating that the firm may have sold most of its holdings in the company. It is not clear why the holding has been reduced, but the firm may have lost confidence in the company's future earnings.
On the other hand, Signet Financial Management, LLC increased its holding in some companies, indicating confidence in their future prospects. For example, Applied Matls Inc (AMAT) increased by 27.8% in the value of shares held. Similarly, Ross Stores Inc (ROST) and Caterpillar Inc (CAT) saw a 15.7% and 6.6% increase in the value of shares held, respectively.
In conclusion, the Q4 2022 vs. Q1 2023 13F holdings comparison of Signet Financial Management, LLC provides insights into the firm's investment strategy, which combines both passive and active investment strategies. The changes in holdings suggest that the firm has a positive outlook on the performance of most of its top holdings, while reducing exposure to some of the funds it has lost confidence in. As an investor, regularly reviewing your portfolio's performance and making necessary changes to align with your investment goals is crucial for growing your wealth.
Other Posts
- Tuttle Capital Management, LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Bishop Rock Capital's Q3 and Q4 2022 Holdings Comparison: Insights into Their Investment Strategy
- Matthew Goff Investment Advisor, LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- A New Horizon in Finance: How Alter Domus's Strategic Partnership with Cinven Paves the Way for Future Prosperity
- Investing in the Future: Infusive Asset Management Inc. Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Stelac Advisory Services LLC's Q3 vs. Q4 2022 13F Holdings: Notable Changes and Their Implications.
- Navigating Market Shifts: Analyzing Summit Financial Group's Tactical Investment Realignments
- Evanson Asset Management, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Signet Financial Management, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Saghmos Therapeutics: Fred Hassan Appointed Chairman of the Board of Directors